Search research articles
Contact Us
Filters
Showing results (201-210 of 293) with videos related to
Page
of 30
Sort By:
JAMA Oncology
|
September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial
Fatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Joseph A Sparano, Eduard Vrdoljak, Oliver Rixe, et al.
BMJ Open
|
October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
Thomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
Clifford A Hudis, William E Barlow, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study
Lawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Cancer
|
May 17, 2022
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials
Gina Kim, Jessica M Pastoriza, Jiyue Qin, et al.
JAMA Oncology
|
February 17, 2022
Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial
Gelareh Sadigh, Robert J Gray, Joseph A Sparano, et al.
JAMA Network Open
|
November 2, 2021
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Breast Cancer Research and Treatment
|
May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
Lawrence J Solin, Robert Gray, Lori J Goldstein, et al.
Seminars in Oncology
|
February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
Nicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 293) with videos related to
Sort By:
Page
of 30
JAMA Oncology
|
September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial
Fatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2010
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Joseph A Sparano, Eduard Vrdoljak, Oliver Rixe, et al.
BMJ Open
|
October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
Thomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
Clifford A Hudis, William E Barlow, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study
Lawrence J Solin, Robert Gray, Lorie L Hughes, et al.
Cancer
|
May 17, 2022
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials
Gina Kim, Jessica M Pastoriza, Jiyue Qin, et al.
JAMA Oncology
|
February 17, 2022
Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial
Gelareh Sadigh, Robert J Gray, Joseph A Sparano, et al.
JAMA Network Open
|
November 2, 2021
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Breast Cancer Research and Treatment
|
May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
Lawrence J Solin, Robert Gray, Lori J Goldstein, et al.
Seminars in Oncology
|
February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
Nicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Page
of 30